|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | |
| A01N 43/04 | |||
| C07H 21/04 | |||
| A61K 31/07 |
| (11) | Number of the document | 2002018 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07752661.4 |
| Date of filing the European patent application | 2007-03-07 | |
| (97) | Date of publication of the European application | 2008-12-17 |
| (45) | Date of publication and mention of the grant of the patent | 2010-05-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2007/005977 |
| Date | 2007-03-07 |
| (87) | Number | WO 2007/103529 |
| Date | 2007-09-13 |
| (30) | Number | Date | Country code |
| 780228 P | 2006-03-07 | US |
| (72) |
NEUMAN, Benjamin, GB
STEIN, David, A., US
BUCHMEIER, Michael, US
IVERSEN, Patrick, L., US
|
| (73) |
AVI BioPharma, Inc.,
Suite 200, 4575 S.W. Research Way, Corvallis, OR 97333,
US
The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, US |
| (54) | ANTISENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ARENAVIRUS INFECTION |
| ANTISENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ARENAVIRUS INFECTION |